TMDX Financials

TransMedics Group Inc - Financial statements & key metrics

Stock Price

$82.10

Market Cap

$2.53B

P/E Ratio

16.8

EPS

$1.07

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$441.54M

Gross Profit

Operating Income

Net Income

$35.46M

EPS (Diluted)

$1.01

Balance Sheet Highlights

Total Assets

$804.08M

Total Liabilities

$575.47M

Shareholders Equity

Cash & Equivalents

$336.65M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$48.80M

CapEx

Free Cash Flow

Profitability Metrics

Net Margin

27.0%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is TMDX revenue?

TMDX's most recent quarterly revenue was $441.54M. Annual revenue can be calculated by summing the four most recent quarters.

Is TMDX profitable?

TMDX reported a profit of $35.46M in the most recent quarter. The net profit margin is 27.0%.

What is TMDX market cap?

TMDX has a market capitalization of $2.53B, making it a mid-cap stock.

Does TMDX have debt?

View TMDX's balance sheet for debt information.

What is TMDX cash flow?

Cash flow data is available in the full financial statements.